City
Epaper

'Vax drive for teens strengthened India's fight against Covid'

By IANS | Updated: January 13, 2022 21:05 IST

New Delhi, Jan 13 The ongoing vaccination drive for teenagers in the 15-18 age bracket has further strengthened ...

Open in App

New Delhi, Jan 13 The ongoing vaccination drive for teenagers in the 15-18 age bracket has further strengthened India's fight against the Covid-19 pandemic, N.K. Arora, Chairman of the Covid-19 Working Group of National Technical Advisory Group on Immunisation (NTAGI), told on Thursday.

"Vaccinating teenagers will give parents the confidence to send them to school and help them resume normal activities while maintaining Covid appropriate behaviour," Arora said.

Since the beginning of the vaccination drive for the 15 to 18 age group on January 3, over three crore teens have been vaccinated with the first dose so far. As per an estimation, there are around 7.50 crore teens in this age bracket in India to whom vaccine shots will be administered.

Talking about Ahmedabad-based Zydus Cadilla's ZyCovD vaccine, the world's first plasmid-DNA vaccine approved for those above 12 years, Arora said, "Since it is the first DNA vaccine, the government wants to be doubly sure of its safety before providing it to children. So, its first one crore doses will be given to adults."

"The vaccine was found to be absolutely safe and highly efficacious during the trials. We are sure that it will soon be available for children as well," he said.

"Data shows that children are as susceptible to catching the infection as adults are. The vaccine protects against severe disease. The older teenagers are quite socially active and so they are at a higher risk of catching the virus as compared to younger kids.

"

On vaccine's side-effects among teens, Manju Puri, consultant gynaecologist at Lady Hardinge Medical College, said that it is a time-tested technology which is both safe and efficacious.

No major side-effects have been reported yet, she said, adding that children, like adults, may experience mild side-effects such as pain at the vaccine site, fatigue, or mild fever for a few days.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: New DelhiindiaCovid-19 working group of national technical advisory group on immunisationNtagiManju puri
Open in App

Related Stories

National‘Harassing Crores for a Few’: Ex-CEC S.Y. Quraishi Criticises SIR Process at Lokmat National Conclave 2025

NationalLokmat National Conclave 2025: Manoj Jha Flags ‘Freebies Culture’, Says Elections Are No Longer Fair

HockeyIndia Clinches Bronze with 4-2 Win Over Argentina in FIH Men’s Junior Hockey World Cup (VIDEO)

CricketIndia vs South Africa 2025 Schedule: Full List of Matches, Dates, Venues and Fixtures

TechnologyOpenAI Offers ChatGPT Go Free for a Year in India; Check All the Features Users Can Now Access

Health Realted Stories

HealthESIC extends SPREE 2025 till Jan 31 to give employers more time to join

HealthDMK confident of 2026 mandate as Stalin hails 2025 as a landmark year for Tamil Nadu

HealthAIIMS Bhubaneswar performs first liver transplant successfully; patient recovering well

HealthTN contract nurses end protest after govt assures permanent appointments

HealthRenowned Naturopathy Expert Dr. Surabhi Dhanwala to Organise 3 Days Free Healing Camp in Nanded